Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-04-05
2011-04-05
McKane, Joseph K. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C426S649000
Reexamination Certificate
active
07919620
ABSTRACT:
The antihypertensive agent of the present invention contains a soluble silicon compound. The soluble silicon compound is preferably metasilicic acid or a salt thereof. In one embodiment, the antihypertensive agent of the present invention contains deep sea water containing the soluble silicon compound, or a dried product of such deep sea water. It is preferred that in such embodiment, the antihypertensive agent further contains metasilicic acid or a salt thereof. The amount of silicon present in the deep sea water in the form of silicic acid (SiO2—Si) is 25 μM or more. The deep sea water is typically collected at a depth of 300 m or deeper, and preferably at a depth of 600 m or deeper.
REFERENCES:
patent: 10-120578 (1998-05-01), None
patent: 2000-295974 (2000-10-01), None
patent: 2001-048528 (2001-02-01), None
patent: 2001-079566 (2001-03-01), None
patent: 2001-190255 (2001-07-01), None
patent: 2001-190256 (2001-07-01), None
patent: 2003-102423 (2003-04-01), None
patent: 2004-161730 (2004-06-01), None
patent: WO 98/34647 (1998-08-01), None
Birchall et al. “Acute toxicity of aluminium to fish eliminated in silicon-rich acid waters.” Nature 338:6211, 1898. p. 146-148.
Li et al. “Inflammation may be a bridge connecting hypertension and atherosclerosis.” Medical Hypotheses 64 (5), 2005, p. 925-929. Published online Dec. 24, 2004.
Ogura, Takeshi. Machine translation of JP 10-120578. Original document published May 12, 1998. Supplied by Industrial Property Digital Library. <http://www.ipdl.inpit.go.jp/homepg—e.ipdl>.
Yoshinari, Shiyouki. Machine translation of JP 2003-102423. Original document published Apr. 8, 2003. Supplied by Industrial Property Digital Library. <http://www.ipdl.inpit.go.jp/homepg—e.ipdl>.
Aquabiology, vol. 23, No. 4, pp. 342-349, 2001. (with English abstract).
“Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion”, BMJ, vol. 297, pp. 319-328, Jul 30, 1988.
“Magnesium Deficiency and Hypertension: Correlation Between Magnesium-Deficient Diets and Microcirculatory Changes in situ”, Science, vol. 223, pp. 1315-1317, Mar. 23, 1984.
Motoyama, Takaaki et al., “Oral Magnesium Supplementation in Patients with Essential Hypertension”, Hypertension, vol. 13, No. 3, pp. 227-232, Mar. 1989.
J. Loeper et al., “The Physiological Role of The Silicon and Its Antiatheromatous Action”, Silicon and its anti-Atheromatous Action, pp. 281-297, New York, 1978.
Oceanochemistry. M. Nishimura, ed., Sangyourosho Inc., pp. 101-109, Tokyo, 1994.
Aoki, Kyuzo et al., “Decrease in Blood Pressure and Increase in Total Peripheral Vascular Resistance in Supine Resting subjects with Normotension of Essential Hypertension”, Jpn. Heart J., vol. 27, pp. 466-475, Jul. 1986.
Altura M. Burton et al., “Magnesium-Calcium Interrelationships in Vascular Smooth Muscle*)**)”, Mag.-Bull., vol. 8, pp. 338-350, 1986.
Altura M. Burton et al., “Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases1, 2”, Federation Proceedings, vol. 40, No. 12, pp. 2672-2679, Oct. 1981.
Perry, Carole C. et al., “Aspects of the bioinorganic chemistry of silicon in conjunction with the biometals calcium, iron and aluminium”, Journal of Inorganic Biochemistry, vol. 69, pp. 181-191, 1998.
Adler, Andrew J. et al., “Uptake, distribution, and excretion of31silicon in normal rats”, The American Physiological Society, pp. E670-E673, 1986.
Austin, James H., “Silicon Levels in Human Tissues”, pp. 255-269, New York, 1978.
Popplewell, J.F. et al., “Kinetics of uptake and elimination of silicic acid by a human subject: A novel application of32Si and accelerator mass spectrometry”, Journal of Inorganic Biochemistry, vol. 69, pp. 177-180, 1998.
Reffitt, David M. et al., “Silicic acid: its gastrointestinal uptake and urinary excretion in man and effects on aluminum excretion”, Journal of Inorganic Biochemistry, vol. 76, pp. 141-147, 1999.
Rondeau, Virginie et al., “Relation between Aluminum Concentrations in Drinking Water and Alzheimer's Disease: An 8-year Follow-up Study”, American Journal of Epidemiology, vol. 152, No. 1, pp. 59-66, 2000.
W.S. Broecker et al., “Internal Cycling and Throughput”, Pathways from River Mouth to Sea Floor, “Tracers in the Sea”, esp., Chapter 1, pp. 1-9, 1982.
Coral Biotech Kabushiki Kaisha
McKane Joseph K.
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
Otton Alicia L
LandOfFree
Agent for suppressing blood pressure elevation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Agent for suppressing blood pressure elevation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agent for suppressing blood pressure elevation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683659